IL172690A0 - Methods for the diagnosis and prognosis of alzheimer's disease - Google Patents
Methods for the diagnosis and prognosis of alzheimer's diseaseInfo
- Publication number
- IL172690A0 IL172690A0 IL172690A IL17269005A IL172690A0 IL 172690 A0 IL172690 A0 IL 172690A0 IL 172690 A IL172690 A IL 172690A IL 17269005 A IL17269005 A IL 17269005A IL 172690 A0 IL172690 A0 IL 172690A0
- Authority
- IL
- Israel
- Prior art keywords
- prognosis
- alzheimer
- diagnosis
- disease
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0307501A FR2856409B1 (en) | 2003-06-20 | 2003-06-20 | METHODS OF DETECTING ALZHEIMER'S DISEASE |
| PCT/FR2004/001509 WO2004113568A2 (en) | 2003-06-20 | 2004-06-17 | Methods for the diagnosis and prognosis of alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL172690A0 true IL172690A0 (en) | 2006-04-10 |
Family
ID=33484616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL172690A IL172690A0 (en) | 2003-06-20 | 2005-12-19 | Methods for the diagnosis and prognosis of alzheimer's disease |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1639139B1 (en) |
| JP (1) | JP4691491B2 (en) |
| KR (1) | KR101170651B1 (en) |
| CN (1) | CN1809645B (en) |
| AR (1) | AR044492A1 (en) |
| AT (1) | ATE518005T1 (en) |
| AU (1) | AU2004249919B2 (en) |
| BR (1) | BRPI0411658A (en) |
| CA (1) | CA2529633C (en) |
| CY (1) | CY1111970T1 (en) |
| DK (1) | DK1639139T3 (en) |
| ES (1) | ES2370491T3 (en) |
| FR (1) | FR2856409B1 (en) |
| HK (1) | HK1090392A1 (en) |
| HR (1) | HRP20110778T1 (en) |
| IL (1) | IL172690A0 (en) |
| MX (1) | MXPA05012800A (en) |
| NO (1) | NO20060257L (en) |
| PL (1) | PL1639139T3 (en) |
| PT (1) | PT1639139E (en) |
| RU (2) | RU2380423C2 (en) |
| SI (1) | SI1639139T1 (en) |
| TW (1) | TWI352738B (en) |
| WO (1) | WO2004113568A2 (en) |
| ZA (1) | ZA200509945B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103013989A (en) * | 2011-09-23 | 2013-04-03 | 深圳北京大学香港科技大学医学中心 | Single-nucleotide polymorphisms of cyclin dependent kinase 5 related to senile dementia incidence |
| GB201212084D0 (en) * | 2012-07-06 | 2012-08-22 | Randox Lab Ltd | Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment |
| CN102768189B (en) * | 2012-07-30 | 2014-11-19 | 黄石 | Method for screening drugs |
| CN104313144B (en) * | 2014-10-16 | 2017-02-01 | 卫生部北京医院 | Reagent for detecting susceptibility of Alzheimer's disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5853995A (en) * | 1997-01-07 | 1998-12-29 | Research Development Foundation | Large scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6 |
| JP2003509017A (en) * | 1999-08-20 | 2003-03-11 | アクティブ パス ファーマシューティカルズ， インコーポレイテッド | Human ABC2 transporter and uses thereof |
| AU2001276995C1 (en) * | 2000-07-20 | 2006-10-26 | Cephalon, Inc. | Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| JP2004147502A (en) * | 2000-07-26 | 2004-05-27 | Banyu Pharmaceut Co Ltd | Human and rat abca2 gene |
| US20020169137A1 (en) * | 2001-02-09 | 2002-11-14 | Active Pass Pharmaceuticals, Inc. | Regulation of amyloid precursor protein expression by modification of ABC transporter expression or activity |
| CA2449654A1 (en) * | 2001-06-08 | 2002-12-19 | Xenon Genetics, Inc. | Methods for treating disorders of the nervous and reproductive systems |
-
2003
- 2003-06-20 FR FR0307501A patent/FR2856409B1/en not_active Expired - Fee Related
-
2004
- 2004-06-09 AR ARP040101994A patent/AR044492A1/en active IP Right Grant
- 2004-06-17 CN CN2004800172750A patent/CN1809645B/en not_active Expired - Fee Related
- 2004-06-17 EP EP04767370A patent/EP1639139B1/en not_active Expired - Lifetime
- 2004-06-17 PL PL04767370T patent/PL1639139T3/en unknown
- 2004-06-17 CA CA2529633A patent/CA2529633C/en not_active Expired - Fee Related
- 2004-06-17 RU RU2006101561/13A patent/RU2380423C2/en not_active IP Right Cessation
- 2004-06-17 KR KR1020057024490A patent/KR101170651B1/en not_active IP Right Cessation
- 2004-06-17 BR BRPI0411658-5A patent/BRPI0411658A/en not_active IP Right Cessation
- 2004-06-17 AT AT04767370T patent/ATE518005T1/en active
- 2004-06-17 ES ES04767370T patent/ES2370491T3/en not_active Expired - Lifetime
- 2004-06-17 JP JP2006516300A patent/JP4691491B2/en not_active Expired - Fee Related
- 2004-06-17 DK DK04767370.2T patent/DK1639139T3/en active
- 2004-06-17 MX MXPA05012800A patent/MXPA05012800A/en active IP Right Grant
- 2004-06-17 AU AU2004249919A patent/AU2004249919B2/en not_active Ceased
- 2004-06-17 PT PT04767370T patent/PT1639139E/en unknown
- 2004-06-17 WO PCT/FR2004/001509 patent/WO2004113568A2/en active Application Filing
- 2004-06-17 RU RU2009104533/10A patent/RU2483108C2/en not_active IP Right Cessation
- 2004-06-17 SI SI200431759T patent/SI1639139T1/en unknown
- 2004-06-18 TW TW093117572A patent/TWI352738B/en not_active IP Right Cessation
-
2005
- 2005-12-07 ZA ZA200509945A patent/ZA200509945B/en unknown
- 2005-12-19 IL IL172690A patent/IL172690A0/en not_active IP Right Cessation
-
2006
- 2006-01-18 NO NO20060257A patent/NO20060257L/en not_active Application Discontinuation
- 2006-10-10 HK HK06111103.5A patent/HK1090392A1/en not_active IP Right Cessation
-
2011
- 2011-10-26 HR HR20110778T patent/HRP20110778T1/en unknown
- 2011-10-27 CY CY20111101024T patent/CY1111970T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2015025I1 (en) | METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE | |
| IL188165A0 (en) | Method for the diagnosis of alzheimer's disease | |
| EP1813947A4 (en) | Method of examining alzheimer's disease and diagnostic reagent | |
| AU2003206413A8 (en) | Substituted amino carboxamides for the treatment of alzheimer's disease | |
| PT2264018E (en) | Thioflavin derivatives for use in the diagnosis of alzheimer's disease | |
| EP1817050A4 (en) | Diagnosis and treatment of alzheimer's disease | |
| AU2003220096A8 (en) | Methods for alzheimer's disease treatment and cognitive enhancement | |
| EP1656359A4 (en) | Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease | |
| EE200300216A (en) | Radiopharmaceuticals for the diagnosis of Alzheimer's disease | |
| EP1418834A4 (en) | Methods for diagnosing and treating alzheimer's disease and parkinson's disease | |
| ZA200603178B (en) | Quick test for the diagnosis of Alzheimer's disease | |
| AU2001236592A1 (en) | Methods for diagnosis of alzheimer's disease | |
| AU2003254146A1 (en) | Methods for the treatment of parkinson's disease | |
| AU2003303141A1 (en) | Hydroxypropyl amides for the treatment of alzheimer's disease | |
| IL172690A0 (en) | Methods for the diagnosis and prognosis of alzheimer's disease | |
| AU2003273310A1 (en) | Substituted aminoethers for the treatment of alzheimer's disease | |
| GB0414894D0 (en) | Biomarkers of alzheimer's disease | |
| AU2003266302A1 (en) | Method for the diagnosis of alzheimer disease | |
| EP1769089A4 (en) | Methods and compositions for pre-symptomatic or post-symptomatic diagnosis of alzheimer's disease and other neurodegenerative disorders | |
| AU2003236714A8 (en) | Diagnosis of alzheimer's disease based on the habeta42:habeta40 ratio | |
| EP1832877A4 (en) | Method of examining alzheimer's disease | |
| EP1693671A4 (en) | Method of diagnosing alzheimer's disease | |
| AU2003251962A8 (en) | Screening for alzheimer's disease | |
| AU2003299101A1 (en) | Compounds for the treatment of alzheimer's disease | |
| AU2003286530A8 (en) | Substituted peptides useful in the treatment of alzheimer's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |